StockData
BioStem Technologies, Inc. logo

BioStem Technologies, Inc. (BSEM) stock

BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$0.64−0.07 (-10.23%)

Close on Nov 20, 2026Market cap $11.34MP/E –Yield –

BioStem Technologies free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for BioStem Technologies

BioStem Technologies has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More BioStem Technologies figures

See a number that looks wrong?